Data for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine (Study ST000917)
(Analysis AN001497)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 |
|---|---|---|---|---|
| 11b PGF2a | 0.8161 | 1.9989 | 0.4159 | 0.5265 |
| 12,13 diHOME | 2.2254 | 0.4774 | 0.4224 | 0.3674 |
| 13-HODE | 0.5118 | 1.3303 | 0.9161 | 1.3484 |
| 2,3 dinor 8-iso PGF2a | 1.1161 | 0.9952 | 0.8433 | 1.1361 |
| 5-iso PGF2a VI | 1.7229 | 0.8490 | 0.6198 | 0.9793 |
| 8-iso PGF2a III | 1.3282 | 1.1358 | 0.8342 | 0.7768 |
| 9,10 diHOME | 3.2256 | 0.2553 | 0.0922 | 0.1614 |
| 9-HODE | 0.6725 | 1.4696 | 0.6317 | 1.4093 |
| dhk PGD2 | 1.1574 | 0.7471 | 1.0161 | 1.0634 |
| dhk PGE2 | 0.8715 | 1.8655 | 0.4458 | 1.0239 |
| dhk PGF2a | 1.4918 | 0.9267 | 0.6701 | 1.0535 |
| FA(14:0) | 0.5284 | 0.4876 | 1.2696 | 1.6991 |
| FA(15:0) | 0.6407 | 0.5347 | 0.8006 | 2.2195 |
| FA(16:0) | 0.3229 | 0.7194 | 1.0992 | 2.1541 |
| FA(16:1) | 0.2071 | 0.6301 | 1.4362 | 1.5377 |
| FA(17:0) | 0.5170 | 0.6444 | 0.9670 | 2.2594 |
| FA(17:1) | 0.2973 | 0.3273 | 1.7011 | 1.2990 |
| FA(18:0) | 0.2904 | 0.6225 | 0.8008 | 3.0039 |
| FA(18:1) | 0.5898 | 0.8136 | 1.2577 | 1.2798 |
| FA(18:2) | 0.4052 | 1.0629 | 1.3377 | 1.1032 |
| FA(18:3 N3) | 0.5216 | 1.4458 | 1.0648 | 1.2017 |
| FA(18:3 N6) | 0.5507 | 1.0449 | 1.3923 | 0.8866 |
| FA(18:4) | 0.9481 | 1.2528 | 0.7772 | 1.2379 |
| FA(20:0) | 0.2162 | 0.3339 | 0.4986 | 3.5747 |
| FA(20:1) | 0.0944 | 0.2929 | 1.1555 | 3.2950 |
| FA(20:2) | 0.2132 | 0.3037 | 1.0957 | 2.5488 |
| FA(20:3 N3) | 0.7252 | 0.3038 | 1.2973 | 1.8200 |
| FA(20:3 N6) | 0.1605 | 0.0793 | 1.3108 | 2.8120 |
| FA(20:3 N9) | 0.5352 | 0.5749 | 1.1762 | 2.0076 |
| FA(20:4) | 0.1218 | 0.2006 | 1.5330 | 2.1346 |
| FA(20:5) | 0.3324 | 2.2375 | 1.0491 | 1.0309 |
| FA(22:0) | 0.3211 | 0.3427 | 0.3607 | 3.7360 |
| FA(22:1) | 1.1919 | 0.4528 | 0.5658 | 2.2399 |
| FA(22:2) | 1.2053 | 0.4414 | 0.6206 | 2.2446 |
| FA(22:3) | 0.5974 | 0.6753 | 0.2741 | 3.0024 |
| FA(22:4) | 0.2208 | 0.2604 | 1.1440 | 2.5020 |
| FA(22:5 N3) | 0.4936 | 0.3470 | 1.1116 | 2.3198 |
| FA(22:5 N6) | 0.3065 | 0.1641 | 0.9779 | 3.3314 |
| FA(22:6) | 0.4333 | 0.3141 | 1.0420 | 2.5480 |
| FA(23:0) | 0.7947 | 0.6891 | 0.5247 | 2.2072 |
| FA(24:0) | 0.3790 | 0.6535 | 0.4582 | 2.9272 |
| FA(24:1) | 0.5288 | 0.5049 | 0.6679 | 2.8657 |
| FA(26:0) | 0.1474 | 1.3016 | 0.3209 | 3.0161 |
| LTE4 | 2.5878 | 0.5851 | 0.4826 | 0.4500 |
| PGEM | 0.7994 | 0.7916 | 1.5725 | 0.6240 |
| PGF3a | 2.5910 | 0.8996 | 0.3532 | 0.3517 |
| PGFM | 0.3691 | 0.5304 | 2.0535 | 0.4368 |
Factors:
| F1 | Diagnosis:Cirrhosis |
| F2 | Diagnosis:NASH |
| F3 | Diagnosis:Normal |
| F4 | Diagnosis:Steatosis |
